Is Corebridge Financial Inc (CRBG) a risky stock?
As of July 21, 2026, Clavix grades Corebridge Financial Inc (CRBG) C+ for risk, a composite score of 65 out of 100 on an A+ to F scale, which puts CRBG in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CRBG's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CRBG scores on each, as of July 21, 2026.
What's moving CRBG's risk right now
Company-specific signals Clavix flags behind CRBG's current grade, drawn from recent news and filings as of July 21, 2026.
An rating at Dowling & Partners reduced their forward earnings-per-share forecast for Corebridge Financial for fiscal 2026, pointing to lower expected profits and potentially pressuring the stock in the near term.
Piper Sandler and another firm set $36 targets on Corebridge Financial, while Keefe, Bruyette & Woods raised its target to $40, signaling rating confidence that the stock has room to climb further.
Corebridge Financial added new index strategies and growth features to its Max Accumulator+ III product, aiming to draw and keep policyholders and support sales in its Life Insurance segment.
What a C+ grade means
On the Clavix A+ to F scale, CRBG's composite of 65 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CRBG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.